Olanzapine: A new atypical antipsychotic drug

H. Y. Meltzer; H. C. Fibiger

doi:10.1016/0893-133X(95)00197-L

Olanzapine: A new atypical antipsychotic drug

H. Y. Meltzer^*, H. C. Fibiger

^*Corresponding author for this work

Psychiatry and Behavioral Sciences

Research output: Contribution to journal › Editorial › peer-review

78 Scopus citations

Original language	English (US)
Pages (from-to)	111-112
Number of pages	2
Journal	Neuropsychopharmacology
Volume	14
Issue number	2
DOIs	https://doi.org/10.1016/0893-133X(95)00197-L
State	Published - Feb 1996

ASJC Scopus subject areas

Pharmacology
Psychiatry and Mental health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/0893-133X(95)00197-L

Cite this

@article{ff4086b84ea44275a59e19fa48c10c8c,

title = "Olanzapine: A new atypical antipsychotic drug",

author = "Meltzer, {H. Y.} and Fibiger, {H. C.}",

year = "1996",

month = feb,

doi = "10.1016/0893-133X(95)00197-L",

language = "English (US)",

volume = "14",

pages = "111--112",

journal = "Neuropsychopharmacology",

issn = "0893-133X",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Olanzapine

T2 - A new atypical antipsychotic drug

AU - Meltzer, H. Y.

AU - Fibiger, H. C.

PY - 1996/2

Y1 - 1996/2

UR - http://www.scopus.com/inward/record.url?scp=0029659028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029659028&partnerID=8YFLogxK

U2 - 10.1016/0893-133X(95)00197-L

DO - 10.1016/0893-133X(95)00197-L

M3 - Editorial

C2 - 8822530

AN - SCOPUS:0029659028

SN - 0893-133X

VL - 14

SP - 111

EP - 112

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

IS - 2

ER -

Olanzapine: A new atypical antipsychotic drug

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this